Category :

Cancer/Oncology Press Releases

Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks

In this webinar, featured speaker Erin Newburn, Associate Director and Field Applications Scientist from Personalis, Inc. will discuss how a combined whole exome and transcriptome platform such as ACE ImmunoID™ can help to overcome obstacles of immuno-oncology biomarker discovery. Topics include: Generating…

Donor Determined to Shine Light on Cancers of the Hepatobiliary System Gives Second Donation of $10K to The Bili Project Foundation

Donor Determined to Shine Light on Cancers of the Hepatobiliary System Gives Second Donation of $10K to The Bili Project Foundation

The Bili Project Foundation has received a grant of $10,000 from one of its devoted supporters and Biliever’s, Ana Gonzalez. Ana Gonzalez, founder of the Yli Believe Foundation, contributed this grant in honor of her dear father Pedro Gonzalez. He was the loving…

Two Women Scientists Granted $400k for Promising Lung Cancer Research

Two Women Scientists Granted $400k for Promising Lung Cancer Research

Groundbreaking research into the early diagnosis of lung cancer and potential new treatments have been awarded funding through two lung cancer research-focused foundations. Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC)…

CytoTest Boosts Global Sales Team

CytoTest Inc., a cutting-edge molecular diagnostics company headquartered in the National Capital area, today announced the continued expansion of its sales team with the addition of representatives in three major market territories: Tomasz Czerski will act as a VP /…

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

Body Composition in Clinical Trials – From BMI to MRI, New Webinar Hosted by Xtalks

In a live session upcoming on Tuesday, February 13, 2018 at 11 a.m. EST, experts from Biotelemetry and AMRA will discuss alternative methods to BMI for determining body composition in clinical trials. Webinar Details: Body Composition in Clinical Trials –…

CureOne Recognized by Medicare as a Leader in Quality Data Collection and Reporting

CureOne™, a nonprofit movement dedicated to standardizing next generation sequencing (NGS) and connecting it with matched clinical outcome data, has been named a Medicare Quality Clinical Data Registry (QCDR), making it the only registry of its kind to achieve this…

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Addressing Platelet Refractoriness: Giving Hematology-Oncology Patients the Best Chance of Success, New Webinar Hosted by Xtalks

Join the live session on Wednesday, Jan. 24, 2018 with featured speaker Dr. Elisabeth Maurer-Spurej, Founder of LightIntegra Technology and principal inventor of ThromboLUX®. Dr. Maurer-Spurej will introduce activated platelets and their prevalence, discuss the impacts of activated platelet transfusions,…

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

​​​Sci-Engi-Medco Solutions Inc. (SEMCO), a private cancer drug discovery and development company that explores its proprietary small molecule anticancer agent technology, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract from the National…

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes

Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes

A recent study concluded that treatment with paclitaxel weekly had more benefits than treatment with paclitaxel every three weeks for women diagnosed with breast cancer that had spread to the lymph nodes or women diagnosed with breast cancer that hadn't spread to the…

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation, a Canadian biopharmaceutical company developing novel biological therapeutics, has completed a new round of financing led by angel investors and the company’s founding investor. ImmunoBiochem has also expanded its operations and is now located at Johnson & Johnson…

As the Market Prepares for New Regulations Closed System Drug Transfer Set to Grow at CAGR of 10.6 Percent to 2024

As the Market Prepares for New Regulations Closed System Drug Transfer Set to Grow at CAGR of 10.6 Percent to 2024

The risks to patients and caregivers posed by selected drug classes that include cytotoxic drugs routinely used in the treatment of oncology have been known for some time. Drug handling systems commonly known as closed system drug transfer (CSDT) devices, introduced…

Highlands Oncology Group Professional Achieves Certification in Healthcare Compliance

Amber Kandur, of Highlands Oncology Group, Northwest Arkansas’ leading cancer treatment group with locations in Fayetteville and Rogers, recently completed the Certified in Healthcare Compliance (CHC) Examination which earned her the distinction of CHC. Kandur works as a compliance and…

New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials Intelligence is part of Hanson Wade’s Beacon…

Cancer Treatment Group Recognized for Their Support of the Symphony of Northwest Arkansas

Highlands Oncology Group, Northwest Arkansas’ leading cancer treatment group, has been recognized by the Symphony of Northwest Arkansas (SoNA) with the Corporate Sponsorship of the Arts Award for their contributions to SoNA, and music education in the region, for more…

Highlands Oncology Group Physician Voted Best of Best by Readers' Poll

Dr.Hershey Garner, of Highlands Oncology Group, Northwest Arkansas’ leading cancer treatment group, was voted “Best Oncologist” by the Citiscapes Magazine’s 2017 Best of Northwest Arkansas’ Reader’s Poll. Several other Highlands Oncology Group oncologists were voted runner-ups, including: Dr.Hershey Garner, of…

ZCP Will Donate $1 for Every Prescription Processed — 'In Search of Our 2018 Charity(ies) of Choice'

ZCP Will Donate $1 for Every Prescription Processed — 'In Search of Our 2018 Charity(ies) of Choice'

​​​​Zero Copay Program, Inc. (ZCP) came to Long Island this year and took an aggressive stance in the health care service industry. Partnering with pharmacies and health care providers, and working directly with insurance companies, ZCP has challenged the status…

Definiens Strengthens Position as Global Service Provider in Biopharma

Definiens, the leader in Tissue Phenomics® announced the strengthening of its global commercial leadership team by appointing Jacques Corriveau as Vice President and General Manager North America. This addition will support the company’s strategic shift and further growth as an end-to-end…

Definiens Presents Cutting-Edge Data at the 32nd Annual SITC Congress

With the start of the 32nd Annual Meeting (Nov. 8-12) of the Society for Immunotherapy of Cancer (SITC) in National Harbor, Maryland, Definiens, the leader in Tissue Phenomics®, will exhibit key findings highlighting the impact of its end-to-end service portfolio…

Definiens Broadens Immuno-Oncology Service Offer

With the start of the 32nd Annual Meeting (November 8th-12th) of the Society for Immunotherapy of Cancer (SITC) in National Harbor, MD, Definiens, the leader in Tissue Phenomics® and provider of end-to-end solutions for biomarker programs in immuno-oncology, unveils its…

CureOne™ Announces Partnership With Washington University to Advance Cancer Research

CureOne™ Announces Partnership With Washington University to Advance Cancer Research

​​​​​CureOne™ (formerly known as MED-C), an independent nonprofit movement dedicated to standardizing next generation sequencing (NGS) and sharing genomic data with matched clinical outcome data, has formed a key partnership with Washington University School of Medicine in St. Louis. CureOne…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login